(Q39686446)

English

The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state

scientific article published on 30 June 2010

In more languages
default for all languages
No label defined

No description defined

Statements

The clinically approved proteasome inhibitor PS-341 efficiently blocks influenza A virus and vesicular stomatitis virus propagation by establishing an antiviral state (English)
0 references
Sabine Eva Dudek
Christina Luig
Eva-Katharina Pauli
Ulrich Schubert

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit